Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

St Jude CE-marks cardiac ICD (implantable cardioverter defibrillator) and pacemaker devices:

This article was originally published in Clinica

Executive Summary

St Jude Medical has gained the European go-ahead to sell both its rate-adaptive Atlas DR/VR implantable cardioverter defibrillator (ICD) and its Identity pacemaker devices for the treatment of patients with cardiac rhythm abnormalities. The Atlas ICD device, which is implanted under the skin, can deliver several magnitudes of electrical shock to patients with ventricular tachycardia and fibrillation. Separately, the Identity pacemaker device has both a therapeutic and diagnostic capability for pacemaker patients suffering from atrial fibrillation, said the St Paul, Minnesota firm.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT065777

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel